… Our results suggest that the combined THC:CBD-RAGT approach could be useful in …
spasticity-related muscle stiffness, spasms, and pain. Reducing spasticity can be therefore useful to …

… tizanidine (and gabapentin for neuropathic pain) [Citation68] … a recent systematic review and
meta-analysis which found no … of cannabis-based medicine in spasticity caused by multiple …

… countries for chronic cancer pain and multiple sclerosis–related pain CBD: cannabidiol;
CSA… against agents commonly used to treat neuropathic pain remains largely unexamined …

… of cannabis medicine (given as an adjunct to other medication) was found in patients with
chronic pain and spasticity due to multiple … Adverse effects of cannabis medicine are often …

… their meta-analysis on the effect of inhaled herbal cannabis for chronic neuropathic pain, …
neuropathic pain treated with the CBM of THC/CBD sublingual spray for 38 weeks. Only …

… due to adverse effects, “other pain,” neuropathic pain, spasticity, and the global impression
… statistical method for combining results in a meta-analysis, as they synthesized study data …

… CB 1 receptors are widely distributed within the CNS on nerve terminals, including areas …
in alleviating pain (52). There is thus evidence that THC:CBD can be used to treat a variety of …

… the chronic pain treatment, especially in the neuropathic pain (… ’s meta-analysis), using
aerosolized cannabis, showed … analgesics-resistant pain in patients with diabetic neuropathy; the …

… In other ALS cohorts, the prevalence of pain … treatment option in neuropathic and
nonneuropathic pain [29, 30]. However, a study of NPS and TSQM-9 in the context of ALS-related …

… In a systematic review and meta-analysis of the treatment of neuropathic pain which …
Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain…